Member of the Innovation R&D Service Professional Committee of China Pharmaceutical Innovation and Research Development Association(PhIRDA) , Standing Member of the Traditional Chinese Medicine and Natural Medicine Toxicology Professional Committee of Chinese Toxicology Society, Member of the Drug Toxicology Professional Committee of the Chinese Pharmacological Society as well as Secretary-General of Tianjin Pharmacological Society
Member of the 9th Committee of Tianjin Science and Technology Association as well as council member of Tianjin European and American Alumni Association
At the same time, She also serves as a graduate tutor at Tianjin Medical University, Nankai University, China Pharmaceutical University, Tianjin University of Traditional Chinese Medicine, etc.
With 17 years of experience in drug development and 13 years in team management, Dr. Ma is responsible for and focused on drug screening, non-clinical studies and quantitative pharmacology. She has presided over and participated in more than 100 products’ R&D projects, supported products to obtain 5 new drug certificates, 28 clinical approvals, and 3 national and provincial-level science and technology awards. She has published more than 100 papers, including 64 papers in SCI journals, and holds 42 authorized patents in the field.
博士、研究员
天士力研究院 专业院长，药理毒理CNAS实验室主任，天津市131创新人才团队带头人
中国医药创新促进会创新研发服务专业委员会委员、中国毒理学会中药与天然药物毒理专业委员会 常务委员、中国药理学会药物毒理专业委员会 委员、天津市药理学会秘书长、天津市科协第九届委员会 委员、天津市欧美同学会 理事、天津医科大学、南开大学、中国药科大学、天津中医药大学校外专业硕士导师等。
研究方向/成果：有17年药物研发和13年团队管理经验，负责和专注新药筛选、非临床和定量药理研究。主持和参与新产品研发100余项，支持产品获新药证书5项，临床批件28项，获国家学会及省部级科技进步奖3项，累计发表论文100余篇（其中SCI 64篇），授权专利42项。
中国医药创新促进会创新研发服务专业委员会委员、中国毒理学会中药与天然药物毒理专业委员会 常务委员、中国药理学会药物毒理专业委员会 委员、天津市药理学会秘书长、天津市科协第九届委员会 委员、天津市欧美同学会 理事、天津医科大学、南开大学、中国药科大学、天津中医药大学校外专业硕士导师等。
研究方向/成果：有17年药物研发和13年团队管理经验，负责和专注新药筛选、非临床和定量药理研究。主持和参与新产品研发100余项，支持产品获新药证书5项，临床批件28项，获国家学会及省部级科技进步奖3项，累计发表论文100余篇（其中SCI 64篇），授权专利42项。